• 1
    Schumacher HR Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002; 324: 148892.
  • 2
    Willburger RE, Mysler E, Derbot J, Jung T, Thurston H, Kreiss A, et al. Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. Rheumatology (Oxford) 2007; 46: 112632.
  • 3
    Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 245061.
  • 4
    Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland L, Huang B, et al. A phase 2 study of multiple doses of intravenous polyethylene glycol (PEG)-uricase in patients with hyperuricemia and refractory gout [abstract]. Arthritis Rheum 2005; 52 Suppl: S67980.
  • 5
    Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Palo WA, Eustace D, et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum 2005; 52: 91623.
  • 6
    Cheng TT, Lai HM, Chiu CK, Chem YC. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis. Clin Ther 2004; 26: 399406.
  • 7
    Fernandez C, Noguera R, Gonzalez JA, Pascual E. Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide [letter]. J Rheumatol 1999; 26: 22856.
  • 8
    Rubin BR, Burton R, Navarra S, Antigua J, Londono J, Pryhuber KG, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis Rheum 2004; 50: 598606.
  • 9
    Navarra S, Rubin BR, Yu Q, Smugar SS, Tershakovec AM. Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout. Curr Med Res Opin 2007; 23: 168591.
  • 10
    Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21: 13257.
  • 11
    Man CY, Cheung IT, Cameron PA, Rainer TH. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 2007; 49: 6707.
  • 12
    Jones J, Hunter D. Qualitative research: consensus methods for medical and health services research. BMJ 1995; 311: 37680.
  • 13
    Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA Appropriateness Method user's manual. Santa Monica (CA): RAND; 2001.
  • 14
    Trochim WM. An introduction to concept mapping for planning and evaluation. Eval Program Plann 1989; 12: 116.
  • 15
    Shewchuk RM, Rivera PA, Elliott TR, Adams AM. Using cognitive mapping to understand problems experienced by family caregivers of persons with severe physical disabilities. J Clin Psychol Med Settings 2004; 11: 14150.
  • 16
    Shewchuk RM, O'Connor SJ, Fine DJ. Building an understanding of the competencies needed for health administration practice. J Healthc Manag 2005; 50: 3247.
  • 17
    Rosenberg S, Kim MP. The method of sorting as a data-gathering procedure in multivariate research. Multivariate Behav Res 1975; 12: 116.
  • 18
    Kruskal JB, Wish M. Multidimensional scaling. Beverly Hills (CA): Sage; 1978.
  • 19
    Aldenderfer MS, Blashfield RK. Cluster analysis. Beverly Hills (CA): Sage; 1984.
  • 20
    Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004; 51: 3215.
  • 21
    Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, et al. Treatment of chronic gout: can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001; 28: 57780.
  • 22
    Neogi T, Hunter DJ, Chaisson CE, Allensworth Davies D, Zhang Y. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006; 33: 1049.
  • 23
    Facchini FS. Near-iron deficiency-induced remission of gouty arthritis. Rheumatology (Oxford) 2003; 42: 15505.
  • 24
    Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 2006; 12: 615.
  • 25
    Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895900.